1. Home
  2. IBOC vs TMDX Comparison

IBOC vs TMDX Comparison

Compare IBOC & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Bancshares Corporation

IBOC

International Bancshares Corporation

N/A

Current Price

$66.17

Market Cap

4.2B

Sector

Finance

ML Signal

N/A

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

N/A

Current Price

$130.67

Market Cap

4.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IBOC
TMDX
Founded
1966
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
4.6B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
IBOC
TMDX
Price
$66.17
$130.67
Analyst Decision
Strong Buy
Buy
Analyst Count
1
9
Target Price
$85.00
$152.33
AVG Volume (30 Days)
260.6K
788.7K
Earning Date
05-29-2026
01-01-0001
Dividend Yield
2.19%
N/A
EPS Growth
0.76
382.18
EPS
6.62
4.87
Revenue
N/A
$605,494,000.00
Revenue This Year
N/A
$24.12
Revenue Next Year
N/A
$18.69
P/E Ratio
$10.05
$26.69
Revenue Growth
N/A
37.13
52 Week Low
$54.11
$62.42
52 Week High
$75.44
$156.00

Technical Indicators

Market Signals
Indicator
IBOC
TMDX
Relative Strength Index (RSI) 36.64 43.48
Support Level $63.73 $124.45
Resistance Level $68.88 $142.44
Average True Range (ATR) 2.33 8.55
MACD -0.51 -0.60
Stochastic Oscillator 21.55 24.47

Price Performance

Historical Comparison
IBOC
TMDX

About IBOC International Bancshares Corporation

International Bancshares Corp is a multibank financial holding company. The company provides commercial and retail banking services in Texas and Oklahoma. The services provided by the bank include checking, savings, bank cards, lending, insurance, mortgage, investments, and other services.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: